The Evolution of Poly(ADP-Ribose) Polymerase Inhibitors in the Treatment of Breast Cancer

  H&O  Could you describe the indications for olaparib that have been added since it was first approved?  SD  The poly(ADP-ribose) polymerase (PARP) inhibitor olaparib (Lynparza, […]